Irini Gergianaki

1.1k total citations
30 papers, 739 citations indexed

About

Irini Gergianaki is a scholar working on Rheumatology, Immunology and Epidemiology. According to data from OpenAlex, Irini Gergianaki has authored 30 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 13 papers in Immunology and 7 papers in Epidemiology. Recurrent topics in Irini Gergianaki's work include Systemic Lupus Erythematosus Research (12 papers), Atherosclerosis and Cardiovascular Diseases (9 papers) and Liver Disease Diagnosis and Treatment (4 papers). Irini Gergianaki is often cited by papers focused on Systemic Lupus Erythematosus Research (12 papers), Atherosclerosis and Cardiovascular Diseases (9 papers) and Liver Disease Diagnosis and Treatment (4 papers). Irini Gergianaki collaborates with scholars based in Greece, Netherlands and United States. Irini Gergianaki's co-authors include George Βertsias, Prodromos Sidiropoulos, Alessandra Bortoluzzi, Dimitrios T. Boumpas, Antonis Fanouriakis, Christina Adamichou, Ioanna Tsiligianni, Amalia Raptopoulou, Christos Tsatsanis and Argyro Repa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Journal of Behavioral Medicine.

In The Last Decade

Irini Gergianaki

30 papers receiving 728 citations

Peers

Countries citing papers authored by Irini Gergianaki

Since Specialization

Citations

This map shows the geographic impact of Irini Gergianaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irini Gergianaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irini Gergianaki more than expected).

Fields of papers citing papers by Irini Gergianaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irini Gergianaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irini Gergianaki. The network helps show where Irini Gergianaki may publish in the future.

Co-authorship network of co-authors of Irini Gergianaki

This figure shows the co-authorship network connecting the top 25 collaborators of Irini Gergianaki. A scholar is included among the top collaborators of Irini Gergianaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irini Gergianaki. Irini Gergianaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Practice Recommendations for the Management of MASLD in Primary Care: Consensus Results 2024 ·SHILAP Revista de lepidopterología ·Christos Lionis, Sophia Papadakis, Marilena Anastasaki, (unknown), Foteini Anastasiou, Sven Francque, Irini Gergianaki, Juan Manuel Mendive, Maria Marketou, Jean Muris, Spilios Manolakopoulos, George Papatheodoridis, Dimitrios Samonakis, Emmanouil K. Symvoulakis, Ioanna Tsiligianni	5
2	Development and pilot evaluation of an evidence-based algorithm for MASLD (formerly NAFLD) management in primary care in Europe 2024 ·Frontiers in Medicine ·Marilena Anastasaki, Sophia Papadakis, Irini Gergianaki, (unknown), (unknown), (unknown), (unknown), (unknown), Foteini Anastasiou, Juan Manuel Mendive, (unknown), (unknown), Alba Martínez-Escudé, Montserrat Garcı́a-Retortillo, Ger H. Koek, (unknown), Jean Muris, Christos Lionis	2
3	Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe 2023 ·Frontiers in Medicine ·Sophia Papadakis, Marilena Anastasaki, Irini Gergianaki, Ger H. Koek, Juan Manuel Mendive, Foteini Anastasiou, (unknown), Montserrat Garcı́a-Retortillo, Jean Muris, Christos Lionis	7
4	High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete 2021 ·Journal of Clinical Medicine ·Irini Gergianaki, Panagiotis Garantziotis, Christina Adamichou, (unknown), (unknown), Prodromos Sidiropoulos, George Βertsias	36
5	Associations of sense of coherence and self-efficacy with health status and disease severity in COPD 2020 ·npj Primary Care Respiratory Medicine ·Ioanna Tsiligianni, Dimitra Sifaki‐Pistolla, Irini Gergianaki, (unknown), (unknown), (unknown), (unknown), (unknown), Despo Ierodiakonou	12
6	In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment 2019 ·Annals of the Rheumatic Diseases ·Christina Adamichou, Dionysis Nikolopoulos, (unknown), Alessandra Bortoluzzi, Antonis Fanouriakis, Emmanouil Papastefanakis, (unknown), Irini Gergianaki, Prodromos Sidiropoulos, Dimitrios T. Boumpas, George Βertsias	79
7	Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity 2019 ·Annals of the Rheumatic Diseases ·Nikolaos I. Panousis, George Βertsias, Halit Ongen, Irini Gergianaki, Maria G. Tektonidou, Maria Trachana, (unknown), Deborah Bielser, Cédric Howald, Cristina Pamfil, Antonis Fanouriakis, (unknown), Argyro Repa, Prodromos Sidiropoulos, Emmanouil T. Dermitzakis, Dimitrios T. Boumpas	85
8	Assessing spirituality: is there a beneficial role in the management of COPD? 2019 ·npj Primary Care Respiratory Medicine ·Irini Gergianaki, (unknown), Siân Williams, Ioanna Tsiligianni	23
9	Chronic obstructive pulmonary disease and rheumatic diseases: A systematic review on a neglected comorbidity 2019 ·SHILAP Revista de lepidopterología ·Irini Gergianaki, Ioanna Tsiligianni	18
10	In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study. 2019 ·PubMed ·Antonis Fanouriakis, (unknown), Irini Gergianaki, (unknown), Abdülsamet Erden, (unknown), (unknown), (unknown), Argyro Repa, Nikolaos Kougkas, George Βertsias, Dimitrios T. Boumpas, Prodromos Sidiropoulos	7
11	Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus 2018 ·Best Practice & Research Clinical Rheumatology ·Irini Gergianaki, Alessandra Bortoluzzi, George Βertsias	88
12	Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner 2018 ·Frontiers in Medicine ·Irini Gergianaki, George Βertsias	46
13	Is systemic lupus erythematosus different in urban versus rural living environment? Data from the Cretan Lupus Epidemiology and Surveillance Registry 2018 ·Lupus ·Irini Gergianaki, Antonis Fanouriakis, Christina Adamichou, (unknown), N. Mihalopoulos, Stelios Kazadzis, Lida Chatzi, Prodromos Sidiropoulos, Dimitrios T. Boumpas, George Βertsias	18
14	O003 Characterising the role of net-derived IL-33 in SLE pathogenesis 2018 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), Irini Gergianaki, Christina Adamichou, (unknown), Prodromos Sidiropoulos, (unknown), Katerina Gkirtzimanaki, George Βertsias	1
15	Leprosy and Hepatitis C co-infection: Epidemiological data from the Leprosarium, Srinagar, Kashmir, India 2017 ·Leprosy Review ·(unknown), SM Kadri, (unknown), Irini Gergianaki, (unknown), (unknown)	1
16	Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece 2017 ·Annals of the Rheumatic Diseases ·Irini Gergianaki, Antonis Fanouriakis, Argyro Repa, (unknown), Christina Adamichou, (unknown), (unknown), Antonios Bertsias, (unknown), Ioannis Tzanakis, Leda Chatzi, Prodromos Sidiropoulos, Dimitrios T. Boumpas, George Βertsias	83
17	Adaptation to inflammatory rheumatic disease: Do illness representations predict patients’ physical functioning over time? A complex relationship 2017 ·Journal of Behavioral Medicine ·Evangelos C. Karademas, (unknown), Emmanouil Papastefanakis, (unknown), Argyro Repa, Irini Gergianaki, George Βertsias, Prodromos Sidiropoulos, Panagiotis G. Simos	4
18	Cognitive deficits early in the course of rheumatoid arthritis 2016 ·Journal of Clinical and Experimental Neuropsychology ·Panagiotis G. Simos, (unknown), (unknown), Emmanouil Papastefanakis, Nikolaos Kougkas, Antonis Fanouriakis, Irini Gergianaki, George Βertsias, Prodromos Sidiropoulos, Evangelos C. Karademas	18
19	Adaptation to an autoimmune disorder: Does mental flexibility impact illness-related self-regulation? 2015 ·Psychology and Health ·Evangelos C. Karademas, (unknown), (unknown), Emmanouil Papastefanakis, Nikolaos Kougkas, Antonis Fanouriakis, Irini Gergianaki, George Βertsias, Prodromos Sidiropoulos, Panagiotis G. Simos	8
20	Expansion of toll‐like receptor 9–expressing B cells in active systemic lupus erythematosus: Implications for the induction and maintenance of the autoimmune process 2006 ·Arthritis & Rheumatism ·Eva D. Papadimitraki, Christianna Choulaki, (unknown), George Βertsias, Christos Tsatsanis, Irini Gergianaki, Amalia Raptopoulou, H Kritikos, Clio Mamalaki, Prodromos Sidiropoulos, Dimitrios T. Boumpas	154

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact